Condition
Primary Tumor
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Unknown2
Terminated2
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05038358RecruitingPrimary
Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms
NCT02301858Not ApplicableUnknown
Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases
NCT04492735Unknown
The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies
NCT01525745Phase 2TerminatedPrimary
Randomized Study of Stereotactic Body Radiotherapy vs. Conventional Radiation for Spine Metastasis
NCT02410174Phase 1TerminatedPrimary
To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors
Showing all 5 trials